Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001559570-26-000006
Filing Date
2026-04-01
Accepted
2026-04-01 16:17:20
Documents
1
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 form4-04012026_080415.html 4  
1 form4-04012026_080415.xml 4 6350
  Complete submission text file 0001559570-26-000006.txt   7812
Mailing Address C/O INTERCEPT PHARMACEUTICALS, INC. 18 DESBROSSES ST. NEW YORK NY 10013
Business Address
Shapiro David (Reporting) CIK: 0001559570 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40288 | Film No.: 26828473

Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Issuer) CIK: 0001807120 (see all company filings)

EIN.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)